These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 35916713)
1. Fibroblast expression of CD248 may contribute to exacerbation of microvascular damage during systemic sclerosis. Cipriani P; Ruscitti P; Di Cola I; Vomero M; Abbruzzese F; Di Nino E; Ross R; Del Galdo F; Giacomelli R Rheumatology (Oxford); 2023 Mar; 62(3):1317-1325. PubMed ID: 35916713 [TBL] [Abstract][Full Text] [Related]
2. Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy. Di Benedetto P; Liakouli V; Ruscitti P; Berardicurti O; Carubbi F; Panzera N; Di Bartolomeo S; Guggino G; Ciccia F; Triolo G; Cipriani P; Giacomelli R Arthritis Res Ther; 2018 Oct; 20(1):223. PubMed ID: 30285896 [TBL] [Abstract][Full Text] [Related]
3. Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor. Liakouli V; Elies J; El-Sherbiny YM; Scarcia M; Grant G; Abignano G; Derrett-Smith EC; Esteves F; Cipriani P; Emery P; Denton CP; Giacomelli R; Mavria G; Del Galdo F Ann Rheum Dis; 2018 Mar; 77(3):431-440. PubMed ID: 29259049 [TBL] [Abstract][Full Text] [Related]
5. Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts. Liakouli V; Cipriani P; Di Benedetto P; Panzera N; Ruscitti P; Pantano I; Berardicurti O; Carubbi F; Esteves F; Mavria G; Del Galdo F; Giacomelli R Sci Rep; 2019 Mar; 9(1):4589. PubMed ID: 30872612 [TBL] [Abstract][Full Text] [Related]
6. Identification of Cysteine-Rich Angiogenic Inducer 61 as a Potential Antifibrotic and Proangiogenic Mediator in Scleroderma. Tsou PS; Khanna D; Sawalha AH Arthritis Rheumatol; 2019 Aug; 71(8):1350-1359. PubMed ID: 30884213 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis. Yamashita T; Asano Y; Saigusa R; Taniguchi T; Nakamura K; Miura S; Toyama T; Takahashi T; Ichimura Y; Hirabayashi M; Yoshizaki A; Miyagaki T; Sugaya M; Sato S J Dermatol Sci; 2019 Jan; 93(1):24-32. PubMed ID: 30270117 [TBL] [Abstract][Full Text] [Related]
8. Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells. Mazzotta C; Manetti M; Rosa I; Romano E; Blagojevic J; Bellando-Randone S; Bruni C; Lepri G; Guiducci S; Ibba-Manneschi L; Matucci-Cerinic M Arthritis Res Ther; 2017 Feb; 19(1):27. PubMed ID: 28183357 [TBL] [Abstract][Full Text] [Related]
9. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis. Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411 [TBL] [Abstract][Full Text] [Related]
10. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis. Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450 [TBL] [Abstract][Full Text] [Related]
11. Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors. Tsou PS; Wren JD; Amin MA; Schiopu E; Fox DA; Khanna D; Sawalha AH Arthritis Rheumatol; 2016 Dec; 68(12):2975-2985. PubMed ID: 27482699 [TBL] [Abstract][Full Text] [Related]
12. Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis. Andreucci E; Margheri F; Peppicelli S; Bianchini F; Ruzzolini J; Laurenzana A; Fibbi G; Bruni C; Bellando-Randone S; Guiducci S; Romano E; Manetti M; Matucci-Cerinic M; Calorini L Rheumatology (Oxford); 2021 Oct; 60(10):4508-4519. PubMed ID: 33471123 [TBL] [Abstract][Full Text] [Related]
16. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface. Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670 [TBL] [Abstract][Full Text] [Related]
17. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Manetti M; Ibba-Manneschi L; Liakouli V; Guiducci S; Milia AF; Benelli G; Marrelli A; Conforti ML; Romano E; Giacomelli R; Matucci-Cerinic M; Cipriani P Ann Rheum Dis; 2010 Mar; 69(3):598-605. PubMed ID: 19778913 [TBL] [Abstract][Full Text] [Related]
18. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis. Rabquer BJ; Tsou PS; Hou Y; Thirunavukkarasu E; Haines GK; Impens AJ; Phillips K; Kahaleh B; Seibold JR; Koch AE Arthritis Res Ther; 2011 Feb; 13(1):R18. PubMed ID: 21303517 [TBL] [Abstract][Full Text] [Related]
19. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404 [TBL] [Abstract][Full Text] [Related]
20. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study. Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]